Emflazin-M Tablets

Emflazin-M – Enhanced Glycemic Control Combination

Emflazin-M is a potent combination anti-diabetic medication designed for the treatment of adults with type 2 diabetes mellitus. It unites Empagliflozin and Metformin to provide a multi-targeted approach to blood sugar management. This medication is typically used as an adjunct to diet and exercise for patients who require more robust control than monotherapy can provide. By simultaneously stimulating glucose excretion via the kidneys and improving insulin sensitivity in the tissues, Emflazin-M helps maintain stable blood sugar levels around the clock. It provides significant benefits for both metabolic control and long-term cardiovascular health in diabetic patients.

• Combination therapy for type 2 diabetes management.
• Supports stable glycemic control via dual mechanisms.
• Available as: Tablets 12.5/500mg, 12.5/1000mg, and 5/500mg.